Millennium: The Takeda Oncology Company
VELCADE® Bortezomib for Injection and Pipeline Data to Be Highlighted at American Society of Clinical Oncology Annual Meeting
Published in Blood Weekly, June 11th, 2009
Millennium: The Takeda Oncology Company announced that more than 49 oral and poster presentations featuring VELCADE and the Company’s pipeline molecules will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting being held in Orlando, Florida, May 29 – June 2, 2009. These data include two oral presentations on studies examining the use of VELCADE based combinations in patients with previously untreated multiple myeloma (MM), and one poster on the use of a VELCADE based combination in patients with relapsed or refractory follicular lymphoma. Clinical and preclinical data also will be presented on three Millennium oncology pipeline products, including MLN8237, an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-06-11)
More Articles from Blood Weekly
- Massachusetts General Hospital
Automated analysis of MR images may identify early Alzheimer’s disease - Acute Myeloid Leukemia
Investigators at University of Munich release new data on acute myeloid leukemia - Angiotensins
Research on angiotensins described by L.H. Shen and colleagues - Bacteremia
Research in the area of bacteremia reported from G.R. Corey and colleagues - Blood Safety
Reports from University of Washington advance knowledge in blood safety - Candidiasis
Investigators at University of Seville target candidiasis - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
